MarketInOut Stock Screener Log In | Sign Up
 

Revvity Inc

NYSE • Healthcare • Diagnostics & Research • Quote as of 05/22/2026
Revvity Inc stock price and volume chart

Company Profile

IndustryDiagnostics & Research
SectorHealthcare
ExchangeNYSE
Market Capitalization10,816 mln
Float102 mln
Earnings Date08/03/2026

EPS

2.08
Stretched

P / E

46.61
High premium

Piotroski F-Score

6 / 9
Solid

Beneish M-Score

-2.44
Borderline

1-Year Forecast

114
Attractive

Relative Strength

17 / 100
Significantly lagging

Business Description

Revvity Inc., formerly PerkinElmer, is a health sciences company founded in 1937 and based in Waltham, Massachusetts. It provides tools, software, and services that help detect and diagnose a wide range of conditions, from genetic disorders like Down syndrome and muscular dystrophy to infectious diseases, serving everyone from hospitals and research labs to government agencies. The company also supports advanced scientific work in areas such as cancer research, drug discovery, and DNA analysis.

Key Fundamentals

EPS2.08
P/E46.61
ROE3.24
RPS25.36
ROIC3.04
ROA1.96
Interest Cover3.82
EBITDA, mln773
EV / EBITDA19.52
EV / EBIT41.91
Revenue, mln2,902
EV / Revenue5.20

Financial Strength

Altman Z-Score2.3
Piotroski F-Score 6 / 9
Beneish M-Score-2.44
1-Year Target Price114
Shiller PE Ratio21.69
Short Ratio8.85
Short % of Float11.80

Price Performance & Relative Strength

Period Price Performance Relative Strength
1 Week 3.17% 80 / 100   
1 Month 11.24% 92 / 100   
2 Months 1.04% 52 / 100   
6 Months 5.24% 42 / 100   
1 Year 8.24% 36 / 100   



Disclaimer - Privacy Policy - Terms Of Service - Cookie Use Policy - FAQ - Contact Us